CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 833 of 865
Non-Antibody Products
Page 833 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Upadacitinib | A JAK1 inhibitor (IC50 = 47 nM); selective for JAK1 over JAK3 and Tyk2 (IC… | 5 mg | 29706-5 | More Info |
| UPF-1069 | A PARP inhibitor that demonstrates a modest preference for PARP2 over PARP… | 1 mg | 17760-1 | More Info |
| UPF-1069 | A PARP inhibitor that demonstrates a modest preference for PARP2 over PARP… | 10 mg | 17760-10 | More Info |
| UPF-1069 | A PARP inhibitor that demonstrates a modest preference for PARP2 over PARP… | 5 mg | 17760-5 | More Info |
| UPF-1069 | A PARP inhibitor that demonstrates a modest preference for PARP2 over PARP… | 50 mg | 17760-50 | More Info |
| UPF-648 | An inhibitor of kynurenine 3-monooxygenase (IC50 = 40 nM); increases kynur… | 1 mg | 32860-1 | More Info |
| UPF-648 | An inhibitor of kynurenine 3-monooxygenase (IC50 = 40 nM); increases kynur… | 10 mg | 32860-10 | More Info |
| UPF-648 | An inhibitor of kynurenine 3-monooxygenase (IC50 = 40 nM); increases kynur… | 5 mg | 32860-5 | More Info |
| Uprosertib | A selective, orally bioavailable inhibitor of Akt (IC50s = 180, 328, and 3… | 1 mg | 19904-1 | More Info |
| Uprosertib | A selective, orally bioavailable inhibitor of Akt (IC50s = 180, 328, and 3… | 10 mg | 19904-10 | More Info |
| Uprosertib | A selective, orally bioavailable inhibitor of Akt (IC50s = 180, 328, and 3… | 25 mg | 19904-25 | More Info |
| Uprosertib | A selective, orally bioavailable inhibitor of Akt (IC50s = 180, 328, and 3… | 5 mg | 19904-5 | More Info |
| Uracil | A pyrimidine nucleoside; a fundamental component of RNA where it binds to… | 100 g | 26088-100 | More Info |
| Uracil | A pyrimidine nucleoside; a fundamental component of RNA where it binds to… | 250 g | 26088-250 | More Info |
| Uracil | A pyrimidine nucleoside; a fundamental component of RNA where it binds to… | 50 g | 26088-50 | More Info |
| Uracil | A pyrimidine nucleoside; a fundamental component of RNA where it binds to… | 500 g | 26088-500 | More Info |
| Uracil-13C,15N2 | An internal standard for the quantification of uracil by GC- or LC-MS | 1 mg | 33997-1 | More Info |
| Uracil-13C,15N2 | An internal standard for the quantification of uracil by GC- or LC-MS | 10 mg | 33997-10 | More Info |
| Uracil-13C,15N2 | An internal standard for the quantification of uracil by GC- or LC-MS | 25 mg | 33997-25 | More Info |
| Uracil-13C,15N2 | An internal standard for the quantification of uracil by GC- or LC-MS | 5 mg | 33997-5 | More Info |
| Uracil-d4 | An internal standard for the quantification of uracil by GC- or LC-MS | 10 mg | 36318-10 | More Info |
| Uracil-d4 | An internal standard for the quantification of uracil by GC- or LC-MS | 100 mg | 36318-100 | More Info |
| Uracil-d4 | An internal standard for the quantification of uracil by GC- or LC-MS | 50 mg | 36318-50 | More Info |
| Urapidil (hydrochloride) | An α1-AR antagonist and partial 5-HT1A agonist; selectively binds to… | 1 g | 29004-1 | More Info |
| Urapidil (hydrochloride) | An α1-AR antagonist and partial 5-HT1A agonist; selectively binds to… | 250 mg | 29004-250 | More Info |
| Urapidil (hydrochloride) | An α1-AR antagonist and partial 5-HT1A agonist; selectively binds to… | 500 mg | 29004-500 | More Info |
| URB447 | A CB1 receptor antagonist and CB2 receptor agonist; inhibits the binding o… | 10 mg | 13261-10 | More Info |
| URB447 | A CB1 receptor antagonist and CB2 receptor agonist; inhibits the binding o… | 25 mg | 13261-25 | More Info |
| URB447 | A CB1 receptor antagonist and CB2 receptor agonist; inhibits the binding o… | 5 mg | 13261-5 | More Info |
| URB447 | A CB1 receptor antagonist and CB2 receptor agonist; inhibits the binding o… | 50 mg | 13261-50 | More Info |
| URB597 | A potent and selective inhibitor of FAAH (IC50 = 4.6 nM in brain membranes… | 10 mg | 10046-10 | More Info |
| URB597 | A potent and selective inhibitor of FAAH (IC50 = 4.6 nM in brain membranes… | 100 mg | 10046-100 | More Info |
| URB597 | A potent and selective inhibitor of FAAH (IC50 = 4.6 nM in brain membranes… | 5 mg | 10046-5 | More Info |
| URB597 | A potent and selective inhibitor of FAAH (IC50 = 4.6 nM in brain membranes… | 50 mg | 10046-50 | More Info |
| URB602 | A selective inhibitor of MAGL (IC50 = 28 µM for the rat brain enzyme… | 10 mg | 10007457-10 | More Info |
| URB602 | A selective inhibitor of MAGL (IC50 = 28 µM for the rat brain enzyme… | 100 mg | 10007457-100 | More Info |
| URB602 | A selective inhibitor of MAGL (IC50 = 28 µM for the rat brain enzyme… | 5 mg | 10007457-5 | More Info |
| URB602 | A selective inhibitor of MAGL (IC50 = 28 µM for the rat brain enzyme… | 50 mg | 10007457-50 | More Info |
| URB754 | A potent and noncompetitive inhibitor of MAGL (IC50 = 200 nM for the recom… | 10 mg | 10007691-10 | More Info |
| URB754 | A potent and noncompetitive inhibitor of MAGL (IC50 = 200 nM for the recom… | 100 mg | 10007691-100 | More Info |
| URB754 | A potent and noncompetitive inhibitor of MAGL (IC50 = 200 nM for the recom… | 5 mg | 10007691-5 | More Info |
| URB754 | A potent and noncompetitive inhibitor of MAGL (IC50 = 200 nM for the recom… | 50 mg | 10007691-50 | More Info |
| URB937 | A potent FAAH inhibitor (IC50 = 26.8 nM, in vitro; ED50 = 0.2 mg / kg in m… | 10 mg | 10674-10 | More Info |
| URB937 | A potent FAAH inhibitor (IC50 = 26.8 nM, in vitro; ED50 = 0.2 mg / kg in m… | 100 mg | 10674-100 | More Info |
| URB937 | A potent FAAH inhibitor (IC50 = 26.8 nM, in vitro; ED50 = 0.2 mg / kg in m… | 5 mg | 10674-5 | More Info |
| URB937 | A potent FAAH inhibitor (IC50 = 26.8 nM, in vitro; ED50 = 0.2 mg / kg in m… | 50 mg | 10674-50 | More Info |
| UR-144-d5 | An internal standard for the quantification of UR-144 by GC- or LC-MS; reg… | 1 mg | 11772-1 | More Info |
| UR-144-d5 | An internal standard for the quantification of UR-144 by GC- or LC-MS; reg… | 5 mg | 11772-5 | More Info |
| UR-144-d5 | An internal standard for the quantification of UR-144 by GC- or LC-MS; reg… | 500 µg | 11772-500 | More Info |
| Urdamycin A | A bacterial metabolite; active against a variety of bacteria, but not S. c… | 1 mg | 29510-1 | More Info |
| Urdamycin B | A glycoside bacterial metabolite with antibacterial and anticancer activit… | 1 mg | 29770-1 | More Info |
| UR-144 Degradant | A common impurity observed during GC-MS analysis of samples containing UR-… | 1 mg | 11928-1 | More Info |
| UR-144 Degradant | A common impurity observed during GC-MS analysis of samples containing UR-… | 10 mg | 11928-10 | More Info |
| UR-144 Degradant | A common impurity observed during GC-MS analysis of samples containing UR-… | 5 mg | 11928-5 | More Info |
| UR-144 Degradant N-pentanoic acid metabolite | A potential phase I metabolite of a degradation product observed during GC… | 1 mg | 9001453-1 | More Info |
| UR-144 Degradant N-pentanoic acid metabolite | A potential phase I metabolite of a degradation product observed during GC… | 10 mg | 9001453-10 | More Info |
| UR-144 Degradant N-pentanoic acid metabolite | A potential phase I metabolite of a degradation product observed during GC… | 5 mg | 9001453-5 | More Info |
| UR-144-d5 (exempt preparation) | An internal standard for the quantification of UR-144 by GC- or LC-MS; pro… | 1 mg | 22869-1 | More Info |
| Urea Fluorometric Assay Kit | Urea is the final degradation product of protein and amino acid metabolism… | 96 Well | 700620-96WELLS | More Info |
| Ureidosuccinic Acid | An intermediate in pyrimidine biosynthesis; inhibits antitumor activity an… | 1 g | 34126-1 | More Info |
| Ureidosuccinic Acid | An intermediate in pyrimidine biosynthesis; inhibits antitumor activity an… | 10 g | 34126-10 | More Info |
| Ureidosuccinic Acid | An intermediate in pyrimidine biosynthesis; inhibits antitumor activity an… | 5 g | 34126-5 | More Info |
| Uric Acid Assay Kit | Cayman's Uric Acid Assay Kit provides fluorescence- or colorimetric-based… | 96 Well | 700320-96WELLS | More Info |
| Uric Acid (sodium salt) | An end product of purine metabolism in humans that is mainly excreted in u… | 2 mg | 16219-2 | More Info |
| Uridine | A pyrimidine nucleoside; forms complementary base pairs with adenosine in… | 10 g | 20300-10 | More Info |
| Uridine | A pyrimidine nucleoside; forms complementary base pairs with adenosine in… | 25 g | 20300-25 | More Info |
| Uridine | A pyrimidine nucleoside; forms complementary base pairs with adenosine in… | 5 g | 20300-5 | More Info |
| Uridine | A pyrimidine nucleoside; forms complementary base pairs with adenosine in… | 50 g | 20300-50 | More Info |
| Uridine-d2 | An internal standard for the quantification of uridine by GC- or LC-MS | 1 mg | 36317-1 | More Info |
| Uridine-d2 | An internal standard for the quantification of uridine by GC- or LC-MS | 10 mg | 36317-10 | More Info |
| Uridine-d2 | An internal standard for the quantification of uridine by GC- or LC-MS | 25 mg | 36317-25 | More Info |
| Uridine-d2 | An internal standard for the quantification of uridine by GC- or LC-MS | 5 mg | 36317-5 | More Info |
| Uridine 5'-methylenediphosphate (sodium salt) | A P2Y14 receptor agonist; selectively inhibits cAMP production in cells ex… | 2 mg | 38691-2 | More Info |
| Uridine-5'-monophosphate | A ribonucleotide | 1 g | 35382-1 | More Info |
| Uridine-5'-monophosphate | A ribonucleotide | 5 g | 35382-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile